Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-010484

VP Clinical Reg Affairs bought 500 shares at $16.74 ($8,370)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Jaye VP Clinical Reg Affairs 2022-04-19 Purchase +500 $16.74 $8,370 255,995 D
Open-market purchases · 500 sh · avg $16.74 · $8,370
Loading xslF345X03/ownership.xml…